The Patent Finder

Antibody Formulations and Methods of Making Same

AbbVie Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application 61/004,992, filed Nov 30, 2007. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,883,146Protein Formulations and Methods of Making Same
In force
 · High confidence
AbbVie Biotechnology Ltd.In force
High confidence
US 9,085,619Anti-Tnf Antibody Formulations
In force
 · High confidence
AbbVie Biotechnology Ltd.In force
High confidence
US 11,167,030Protein Formulations and Methods of Making Same
In force
 · Medium confidence
AbbVie Biotechnology Ltd.In force
Medium confidence
US 11,191,834Protein Formulations and Methods of Making Same
In force
 · Medium confidence
AbbVie Biotechnology Ltd.In force
Medium confidence
US 8,420,081Antibody Formulations and Methods of Making Same
In force
 · High confidence
AbbVie Biotechnology Ltd.In force
High confidence
US 8,821,865HIGH CONCENTRATION ANTI-TNFalpha ANTIBODY LIQUID FORMULATIONS
In force
 · High confidence
AbbVie Biotechnology Ltd.In force
High confidence
US 12,799,192Risankizumab Compositions
In force
 · High confidence
AbbVie Inc.In force
High confidence
US 12,502,420Clostridium botulinum Serotype A Neurotoxin (BoNT/A) Sequence Variants
In force
 · High confidence
AbbVie Inc.In force
High confidence
Application 13/794,881Ultrafiltration and Diafiltration Formulation Methods for Protein Processing
Abandoned
Abandoned Dec 21, 2015
AbbVie, Inc.AbandonedAbandoned Dec 21, 2015
Application 14/473,775HIGH CONCENTRATION ANTI-TNFalpha ANTIBODY FORMULATIONS
Abandoned
Abandoned Dec 15, 2015
AbbVie Biotechnology Ltd.AbandonedAbandoned Dec 15, 2015
22 more patents in this group · Pro
10 of 32 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 32.
Upgrade to Pro
8 of these are in force and held by AbbVie Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited